865 related articles for article (PubMed ID: 22333029)
1. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
[TBL] [Abstract][Full Text] [Related]
2. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
[TBL] [Abstract][Full Text] [Related]
4. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
[TBL] [Abstract][Full Text] [Related]
5. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
6. [Effect of duration of clopidogrel use on clinical follow-up outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Yang J; Shen ZJ; Fang Q; Zhang SY; Fan ZJ; Jin XF; Xie HZ; Liu ZY
Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(24):1682-5. PubMed ID: 20979877
[TBL] [Abstract][Full Text] [Related]
7. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
[TBL] [Abstract][Full Text] [Related]
8. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
Chong E; Poh KK; Liang S; Lee RC; Low A; Teo SG; Tan HC
J Interv Cardiol; 2010 Apr; 23(2):101-8. PubMed ID: 20236214
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Kaya MG; Uyarel H; Akpek M; Kalay N; Ergelen M; Ayhan E; Isik T; Cicek G; Elcik D; Sahin O; Cosgun SM; Oguzhan A; Eren M; Gibson CM
Am J Cardiol; 2012 Feb; 109(4):486-91. PubMed ID: 22100027
[TBL] [Abstract][Full Text] [Related]
10. [Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].
Han YL; Deng J; Jing QM; Wang SL; Ma YY; Luan B
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):483-6. PubMed ID: 16842659
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction.
D'Ascenzo F; Gonella A; Quadri G; Longo G; Biondi-Zoccai G; Moretti C; Omedè P; Sciuto F; Gaita F; Sheiban I
Am J Cardiol; 2011 Mar; 107(5):651-4. PubMed ID: 21195375
[TBL] [Abstract][Full Text] [Related]
12. Impact of multivessel coronary disease on one-year clinical outcomes and five-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
Lekston A; Tajstra M; Gąsior M; Gierlotka M; Pres D; Hudzik B; Trzeciak P; Kalarus Z; Poloński L; Zembala M
Kardiol Pol; 2011; 69(4):336-43. PubMed ID: 21523666
[TBL] [Abstract][Full Text] [Related]
13. Primary coronary angioplasty in patients with ST segment elevation acute myocardial infarction and diabetes.
Dudek D; Mielecki W; Wizimirski M; Rakowski T; Dziewierz A; Sorysz D; Tomala M; Zorkun C; Zmudka K; Dubiel JS
Kardiol Pol; 2004 Sep; 61(9):232-41; discussion 242. PubMed ID: 15531935
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial.
Violini R; Musto C; De Felice F; Nazzaro MS; Cifarelli A; Petitti T; Fiorilli R
J Am Coll Cardiol; 2010 Feb; 55(8):810-4. PubMed ID: 20170821
[TBL] [Abstract][Full Text] [Related]
15. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
[TBL] [Abstract][Full Text] [Related]
16. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
Campo G; Saia F; Percoco G; Manari A; Santarelli A; Vignali L; Varani E; Benassi A; Sangiorgio P; Tarantino F; Magnavacchi P; De Palma R; Guastaroba P; Marzocchi A
Int J Cardiol; 2010 Apr; 140(2):154-60. PubMed ID: 19056134
[TBL] [Abstract][Full Text] [Related]
18. Suboptimal coronary blood flow after primary percutaneous coronary intervention for acute myocardial infarction: incidence, a simple risk score, and prognosis.
Uyarel H; Ayhan E; Cicek G; Isik T; Ugur M; Bozbay M; Yildirim E; Ergelen M; Eren M
Coron Artery Dis; 2012 Mar; 23(2):98-104. PubMed ID: 22318130
[TBL] [Abstract][Full Text] [Related]
19. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
[TBL] [Abstract][Full Text] [Related]
20. Value of blood adipose tissue hormones concentration--adiponectin, resistin and leptin in the prediction of major adverse cardiac events (MACE) in 1-year follow-up after primary percutaneous coronary intervention in ST-segment elevation acute myocardial infarction.
Piestrzeniewicz K; Luczak K; Goch JH
Neuro Endocrinol Lett; 2008 Aug; 29(4):581-8. PubMed ID: 18766137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
